Inflammatory response and the endothelium

Thrombosis Research

Volumn 114, Issue 5-6 SPEC. ISS., 2004, Pages 329-334

  Meroni, P L ^a,e   Borghi, M O ^a   Raschi, E ^a   Ventura, D ^a   Sarzi Puttini, P C ^b   Atzeni, F ^b   Lonati, L ^a   Parati, G ^a   Tincani, A ^c   Mari, D ^a   Tedesco, F ^d  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SPEDALI CIVILI   (Italy)

^d UNIVERSITY OF TRIESTE   (Italy)

^e ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

Adhesion molecules; Cytokines; Endothelial cells; Flow mediated vasodilation; Tissue plasminogen activator; von Willebrand factor

Indexed keywords

BETA2 GLYCOPROTEIN 1; CELL ADHESION MOLECULE; PHOSPHOLIPID ANTIBODY; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRACHIAL ARTERY; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; INFLAMMATION; PLEIOTROPY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TITRIMETRY; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASODILATATION;

ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; CELL ADHESION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; INFLAMMATION; LUPUS; MALE; MODELS, BIOLOGICAL; PHENOTYPE; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

EID: 7044227591     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.06.045     Document Type: Article

References (45)

1. L.O. Carreras, and J.G. Vermylen Lupus anticoagulant and thrombosis: possible role of inhibition of prostacyclin formation Thromb. Haemost. 48 1982 38 40
2. R. Simantov, J.M. La Sala, S.K. Lo, A.E. Gharavi, L.R. Sammaritano, and J.E. Salmon Activation of cultured vascular endothelial cells by antiphospholipid antibodies J. Clin. Invest. 96 1995 2211 2219
3. N. Del Papa, L. Guidali, L. Spatola, P. Bonara, M.O. Borghi, and A. Tincani Relationship between anti-phospholipid and anti-endothelial antibodies III: β2-glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules Clin. Exp. Rheumatol. 13 1995 179 186
4. N. Del Papa, L. Guidali, A. Sala, C. Buccellati, M.A. Khamashta, and K. Ichikawa Endothelial cell as target for antiphospholipid antibodies Arthritis Rheum. 40 1997 551 561
5. M. Dueymes, J.C. Piette, M. Le Tonqueze, B. Bendaoud, R. Roue, and M. Garre Role of β2-glycoprotein I in the anti-phospholipid antibody binding to endothelial cells Lupus 4 1995 179 186
6. J. George, M. Blank, Y. Levy, P. Meroni, M. Damianovich, and A. Tincani Differential effects of anti-beta 2 glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome Circulation 97 1998 900 906
7. S.S. Pierangeli, M. Colden-Stanfield, X. Liu, J.H. Barker, G.L. Anderson, and E.N. Harris Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo Circulation 99 1999 1997 2002
8. C.S. Cho, M.L. Cho, P.P. Chen, S.Y. Min, S.Y. Hwang, and K.S. Park Antiphospholipid antibodies induce monocyte chemoattractant protein-1 in endothelial cells J. Immunol. 168 2002 4209 4215
9. P.L. Meroni, A. Tincani, N. Sepp, E. Raschi, C. Testoni, and E. Corsini Endothelium and the brain in CNS lupus Lupus 12 2003 919 928
10. S. Dunoyer-Geindre, P. de Moerloose, B. Galve-de Rochemonteix, G. Reber, and E.K. Kruithof NFkappaB is an essential intermediate in the activation of endothelial cells by anti-beta(2)-glycoprotein 1 antibodies Thromb. Haemost. 88 2002 851 857
11. D.W. Branch, and G.M. Rodgers Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis Am. J. Obstet. Gynecol. 168 1993 206 210
12. P.L. Meroni, E. Raschi, C. Testoni, A. Tincani, and G. Balestrieri Antiphospholipid antibodies and the endothelium Rheum. Dis. Clin. North Am. 27 2001 587 602
13. J.H. Rand Molecular pathogenesis of the antiphospholipid syndrome Circ. Res. 90 2002 29 37
14. T. Atsumi, M.A. Khamashta, R.S. Haworth, G. Brooks, O. Amengual, and K. Ichikawa Arterial disease and thrombosis in the antiphospholipid syndrome: a pathogenic role for endothelin 1 Arthritis Rheum. 41 1998 800 807
15. N. Nakamura, Y. Shidara, N. Kawaguchi, C. Azuma, N. Mitsuda, and S. Onishi Lupus anticoagulant autoantibody induces apoptosis in HUVEC: involvement of annexin V Biochem. Biophys. Res. Commun. 205 1994 1488 1493
16. A. Bordron, M. Dueymes, Y. Levy, C. Jamin, L. Ziporen, and J.C. Piette Anti-endothelial cell antibody binding makes negatively charged phospholipids accessible to antiphospholipid antibodies Arthritis Rheum. 41 1998 1738 1747
17. S. Dunoyer-Geindre, P. de Moerloose, B. Galve-de Rochemonteix, G. Reber, and E.K. Kruithof Interaction of anti-phospholipid antibodies with late endosomes of human endothelial cells Arterioscler. Thromb. Vasc. Biol. 20 2000 563 574
18. J.C. Zhang, R. Sakthivel, D. Kniss, C.H. Graham, D.K. Strickland, and K.R. McCrae Detection of endothelial cell reactive immunoglobulin in patients with anti-phospholipid antibodies Br. J. Haematol. 79 1991 595 605
19. N. Del Papa, G. Conforti, D. Gambini, L. La Rosa, A. Tincani, and D. D'Cruz Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis Clin. Immunol. Immunopathol. 70 1994 211 216
20. R. Revelen, A. Bordron, M. Dueymes, P. Youinou, and J. Arvieux False positivity in a cyto-ELISA for anti-endothelial cell antibodies caused by heterophile antibodies to bovine serum proteins Clin. Chem. 46 2000 273 278
21. S.K. Moestrup, I. Schousboe, C. Jacobsen, J.R. Leheste, E.I. Christensen, and T.E. Willnow β2-Glycoprotein-I (apolipoprotein H) and β2-glycoprotein-I-phospholipid complex harbor a recognition site for the endocytic receptor megalin J. Clin. Invest. 102 1998 902 909
22. W. Cao, T. Atsumi, and Y. Yamashita A possible binding of β2-glycoprotein I to megaline, an endocytic receptor on trophoblast J. Autoimmun. 2000 A61
23. K. Ma, R. Simantov, J.C. Zhang, R. Silverstein, K.A. Hajjar, and K.R. McCrae High affinity binding of β2-glycoprotein I to human endothelial cells is mediated by annexin II J. Biol. Chem. 20 2000 15541 15548
24. K.A. Hajjar, A.T. Jacovina, and J. Chacko An endothelial cell receptor for plasminogen/tissue plasminogen activator: I. Identity with annexin II J. Biol. Chem. 269 1994 21191 21197
25. K.A. Hajjar, L. Mauri, A.T. Jacovina, F. Zhong, U.A. Mirza, and J.C. Padovan Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine J. Biol. Chem. 273 1998 9987 9993
26. G.M. Cesarman, C.A. Guevara, and K.A. Hajjar An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA): II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation J. Biol. Chem. 269 1994 21198 21203
27. M. Muzio, G. Natoli, S. Saccani, M. Levrero, and A. Mantovani The human toll signaling pathway: divergence of nuclear factor kB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6) J. Exp. Med. 187 1998 2097 2101
28. E. Raschi, C. Testoni, D. Bosisio, M.O. Borghi, T. Koike, and A. Mantovani Role of the MyD88 transduction signaling pathway in endothelial activation by anti-phospholipid antibodies Blood 101 2003 3495 3500
29. R. Medzhitov Toll-like receptors and innate immunity Nat. Rev., Immunol. 1 2001 135 145
30. A.E. Gharavi, S.S. Pierangeli, M. Colden-Stanfield, X.W. Liu, R.G. Espinola, and E.N. Harris GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro J. Immunol. 163 1999 2922 2927
31. A.E. Gharavi, S.S. Pierangeli, R.G. Espinola, X.W. Liu, M. Colden-Stanfield, and E.N. Harris Antiphospholipid antibodies induced in mice by immunization with cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo Arthritis Rheum. 46 2002 545 552
32. M. Blank, I. Krause, M. Fridkin, N. Keller, J. Kopolovic, and I. Goldberg Bacterial induction of autoantibodies to β2-glycoprotein-1 accounts for the infectious etiology of antiphospholipid syndrome J. Clin. Invest. 109 2002 797 804
33. Y. Shoenfeld Etiology and pathogenetic mechanisms of the anti-phospholipid syndrome unraveled Trends Immunol. 24 2003 2 4
34. J.A. McIntyre Immune recognition at the maternal-fetal interface: overview Am. J. Reprod. Immunol. 28 1992 127 131
35. L. La Rosa, P.L. Meroni, A. Tincani, G. Balestrieri, D. Faden, and A. Lojacono β2-Glycoprotein I and placental anti-coagulant protein I in placentae from patients with anti-phospholipid syndrome J. Rheumatol. 21 1994 1684 1698
36. V. Combes, A.C. Simon, G.E. Grau, D. Arnoux, L. Camoin, and F. Sabatier In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant J. Clin. Invest. 104 1999 93 102
37. G. Kaplanski, P. Cacoub, C. Farnarier, V. Marin, R. Gregoire, and A. Gatel Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with the severity of thrombosis Arthritis Rheum. 43 2000 55 64
38. C.J. Frijns, R.H. Derksen, P.G. De Groot, A. Algra, and R. Fijnheer Lupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosus Clin. Exp. Immunol. 125 2001 149 154
39. F.M. Williams, K. Parmar, G.R. Hughes, and B.J. Hunt Systemic endothelial cell markers in primary antiphospholipid syndrome Thromb. Haemost. 84 2000 742 746
40. S.S. Pierangeli, R.G. Espinola, X. Liu, and E.N. Harris Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin Circ. Res. 88 2001 245 250
41. D. Erkan, M.J. Roman, F. Tenedios, and M.D. Lockshin Cardiac involvement in the antiphospholipid syndrome A. Doria P. Pauletto Heart in systemic autoimmune diseases 2004 Elsevier Amsterdam 213 226
42. O.T. Raitakari, and D.S. Celermajer Testing for endothelial dysfunction Ann. Med. 32 2000 293 304
43. M.C. Boffa, and M. Karmochkine Thrombomodulin: an overview and potential implications in vascular disorders Lupus 7 1998 S120 S125
44. F. Dignat-Gorge, and J. Sampol Circulating endothelial cells in vascular disorders: new insights into an old concept Eur. J. Haematol. 65 2000 215 220
45. M.D. Faulx, A.T. Wright, and B.D. Hoit Detection of endothelial dysfunction with brachial artery ultrasound scanning Am. Heart J. 145 2003 943 951